NCT00900224 2023-08-31
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
Unknown
Clinical Trials
14 trialsNCT00898261 2017-05-19
Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia
Eastern Cooperative Oncology Group
Completed
NCT00003931 2016-07-04
Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
Completed
NCT01229956 2016-05-19
Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT01150656 2016-05-18
Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT01229124 2016-05-17
RNA Biomarkers in Tissue Samples From Infants With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT01057095 2015-10-02
Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT00899899 2015-09-30
Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission
Children's Oncology Group
Completed
NCT01041443 2015-06-08
5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
City of Hope Medical Center
Phase 1 Completed
NCT01057303 2015-05-06
Studying Gene Expression in Tissue Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT00723203 2014-09-09
Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
City of Hope Medical Center
Phase 2 Terminated
NCT01251250 2014-01-13
Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia
Roswell Park Cancer Institute
Phase 1 Withdrawn
NCT01653613 2013-07-10
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Unknown
NCT00428077 2011-09-02
Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
OHSU Knight Cancer Institute
Phase 2 Terminated